NCT02844179View on ClinicalTrials.gov

(+)-Alpha-Dihydrotetrabenazine Phase I

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 27, 2017

Study Completion Date

June 27, 2017

Conditions

Healthy Subjects

Interventions

DRUG

HTBZ

Trial Locations (1)

48109

University of Michigan hospitals, Ann Arbor

Sponsors

Collaborators (1)

Adeptio Pharmaceuticals

All Listed Sponsors

collaborator

Adeptio Pharmaceuticals

UNKNOWN

lead

Kirk A. Frey

OTHER